Search Results

11 - 20 of 23 items :

  • Laboratory Medicine x
Clear All
Research progress of siRNA in anti-influenza viral infection

.S. Muslimov A.R. Petrova A.V. Lepik K.V. Okilova M.V. Vasin A.V. Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection Sci. Rep. 2017 7 1 102 [28] Kumar P., Sood V., Vyas R., Gupta N., Banerjea A.C., Khanna M., Potent inhibition of influenza virus replication with novel siRNA-chimeric-ribozyme constructs, Antiviral Res., 2010, 87(2), 204-212. 10.1016/j.antiviral.2010.05.001 Kumar P. Sood V. Vyas R. Gupta N. Banerjea A.C. Khanna M. Potent inhibition of influenza virus replication with novel siRNA

Open access
Research progress in the correlation between oral and stomach Hpinfections

C.M., Pannuti C., Chehter L., Mayer M.P., Lima L.A., Persistence of Helicobacter pylori in the oral cavity after systemic eradication therapy, J. Clin. Periodontol., 2006, 33, 329-333. 10.1111/j.1600-051X.2006.00915.x Gebara E.C. Faria C.M. Pannuti C. Chehter L. Mayer M.P. Lima L.A. Persistence of Helicobacter pylori in the oral cavity after systemic eradication therapy J. Clin. Periodontol. 2006 33 329 333 [4] Forman D., Newell D.G., Fullerton F., Yarnell JW, Stacey AR, Wald N, et al., Association between infection with Helicobacter pylori and risk gastric

Open access
NADPH promotes the rapid growth of the tumor

al., ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells, Mol. Carcinog., 2016, 55(1), 27-39. 10.1002/mc.22255 Holl M. Koziel R. Schäfer G. Pircher H. Pauck A. Hermann M. ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells Mol. Carcinog. 2016 55 1 27 39 [7] Sharpless N.E., Ramsey M.R., ROS as a tumour suppressor, News Views, 2006, 8, 1213-1215. Sharpless N.E. Ramsey M.R. ROS as a tumour suppressor News Views 2006 8 1213 1215 [8] Shan C., Elf S., Ji Q., Kang H

Open access
The mechanism of HBx protein to promote the initiation and progression of hepatocellular carcinoma

transformation of hepatocytes and its regulatory mechanism, Shi Jie Hua Ren Xiao Hua Za Zhi, 2015, 23(05), 741-747. Xia H. Zhu M.Y. Li M.S. The effect of HBx induced alpha fetoprotein expression on malignant transformation of hepatocytes and its regulatory mechanism Shi Jie Hua Ren Xiao Hua Za Zhi 2015 23 05 741 747 [10] Kotake Y., Naemura M., Murasaki C., Inoue Y., Okamoto H., Transcriptional regulation of the p16 tumor suppressor gene, Anticancer Res., 2015, 35(8), 4397-4401. Kotake Y. Naemura M. Murasaki C. Inoue Y. Okamoto H. Transcriptional regulation of the p16 tumor

Open access
The progress in study of fosfomycin

pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review, Int. J. Antimicrob. Agents, 2013, 42(4), 289-293. 10.1016/j.ijantimicag.2013.05.018 Parker S. Lipman J. Koulenti D. Dimopoulos G. Roberts J.A. What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review Int. J. Antimicrob. Agents 2013 42 4 289 293 [19] Gattringer R., Meyer B., Heinz G., Guttmann C., Zeitlinger M., Joukhadar C., Single-dose pharmacokinetics of fosfomycin during continuous

Open access
The function of HBx in HBV-induced hepatocellular carcinoma

statistics in the year 2000. Lancet Oncol 2001; 2:533–543. 10.1016/S1470-2045(01)00486-7 Parkin DM. Global cancer statistics in the year 2000 Lancet Oncol 2001 2 533 543 [2] Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010; 15:5–13. 10.1634/theoncologist.2010-S4-05 Venook AP. Papandreou C. Furuse J. de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective Oncologist 2010 15 5 13 [3] Cancer IARC. Globocan

Open access
Advances in the Treatment of Human Immunodeficiency Virus and Hepatitis B Virus Co-infection

References 1 Lee WM. Hepatitis B virus infection. N Engl J Med,1997,337(24):1733-1745. 2 Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology, 2009, 49 (5Suppl): S138-145. 3 Kourtis AP, Bulterys M, Hu DJ, et al . HIV-HBV coinfection a global challenge. N Engl J Med, 2012, 366(19): 1749-1752. 4 Wang H, Li Y, Zhang C, et al. Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort. AIDS, 2012, 26(14): 1755-1763. 5 Colin JF, Cazals-Hatem D, Loriot MA, et al

Open access
Imaging features of IRIS caused by AIDS and complicated by tuberculosis

mycobacterial infections in HIV-infected individuals receiving antiretrovirals, Lancet Infect. Dis., 2005, 5(6), 361-373. 10.1016/S1473-3099(05)70140-7 Lawn S.D. Bekker L.G. Miller R.F. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals Lancet Infect. Dis. 2005 5 6 361 373 [5] Zhao, Q.X., Sun, Y., He, Y., Li, S.J., Liu, C.L., Clinical analysis of 177 cases of HIV/AIDS complicated with tuberculosis, J. Infect. Dis., 2008, 21(6), 370-373. Zhao Q.X. Sun Y. He Y. Li S.J. Liu C.L. Clinical

Open access
Similarity of regulatory network between leukemia stem cells and normal hemopoietic stem cells

corresponding BMs and PB, respectively. The comparison among the number of DEGs obtained in the four experiments showed that LB cells did not tend to differentiation and CD34+ was more similar to cancer stem cells. The heatmaps of the top 20 DEGs obtained in the four experiments are shown in Figures 2 – 5 , respectively. As shown in Figure 2 , the top 5 ranked DEGs in experiment 1 were GYPA, LCK, ITK, BCL11B, and RHAG. In Figure 3 , the top 5 ranked DEGs were TAL1, RHOH, MYH10, TYROBP, and CFD. In Figure 4 , the top 5 ranked DEGs were CXCR2, MGAM, TNFRSF10C, KCNJ15, and

Open access
Treatment of Helicobacter pylori-associated gastritis using traditional Chinese medicine

] Potamitis G.S., Axon A.T.R., Helicobacter pylori and nonmalignant diseases, Helicobacter, 2015, 20(S1), 26-29. 10.1111/hel.12253 Potamitis G.S. Axon A.T.R. Helicobacter pylori and nonmalignant diseases Helicobacter 2015 20 S1 26 29 [2] Roubaud B.C., Franceschi F., Salles N., Gasbarrini, A., Extragastric diseases and Helicobacter pylori , Helicobacter, 2013, 18(Suppl. 1), 44-51. 10.1111/hel.12077 Roubaud B.C. Franceschi F. Salles N. Gasbarrini A. Extragastric diseases and Helicobacter pylori Helicobacter 2013 18 Suppl. 1 44 51 [3] Venerito M., Vasapolli R., Rokkas

Open access